# SHANGHAI MEDICINES & HEALTH PRODUCTS I/E CORP. · 66-66 · CHINA — FDA import alert red lists: firms subject to detention without physical examination

For SHANGHAI MEDICINES & HEALTH PRODUCTS I/E CORP. · 66-66 · CHINA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is CHINA; product is Kanamycin; product code is 56 D - S 30 Kanamycin (Aminoglycosides), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 27 ZHONGSHAN ROAD (E.1) , Shanghai, Cn-31 CHINA, verified against its source on 2026-09-16.

- **Firm:** SHANGHAI MEDICINES & HEALTH PRODUCTS I/E CORP. _(verified: appears in the quote below)_
- **Import alert:** 66-66
- **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- **Country:** CHINA _(verified: appears in the quote below)_
- **Address:** 27 ZHONGSHAN ROAD (E.1) , Shanghai, Cn-31 CHINA _(verified: appears in the quote below)_
- **Date published:** 09/30/2009 _(verified: appears in the quote below)_
- **Product code:** 56 D - S 30 Kanamycin (Aminoglycosides), Active Pharm Ingred/Chems for Further Manuf _(verified: appears in the quote below)_
- **Product:** Kanamycin _(verified: appears in the quote below)_
- **FDA notes:** 10/10/2000 _(verified: appears in the quote below)_

## What the source says

> SHANGHAI MEDICINES & HEALTH PRODUCTS I/E CORP. Date Published : 09/30/2009 27 ZHONGSHAN ROAD (E.1) , Shanghai, Cn-31 CHINA 56 D - S 30 Kanamycin (Aminoglycosides), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Kanamycin Notes: 10/10/2000

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).